Education
About Us
Working with TipRanks
Follow Us
Biotron Limited (BITRF)
:BITRF
BITRF Stock Chart & Stats
$0.01
<$0.01(21.72%)
At close: 4:00 PM EST
$0.01
<$0.01(21.72%)
Day’s Range― - ―
52-Week Range$0.01 - $0.04
Previous CloseN/A
Volume100.00K
Average Volume (3M)125.00
Market Cap
$4.79M
Enterprise Value$929.61K
Total Cash (Recent Filing)$931.68K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta6.59
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,409,199,200
10 Day Avg. Volume270
30 Day Avg. Volume125
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)3.63
Price to Sales (P/S)1.10
P/FCF Ratio-3.52
Enterprise Value/Market Cap0.19
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit0.51
Enterprise Value/Ebitda-2.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Biotron News
BITRF FAQ
What was Biotron Limited’s price range in the past 12 months?
Biotron Limited lowest stock price was $0.01 and its highest was $0.04 in the past 12 months.
What is Biotron Limited’s market cap?
Biotron Limited’s market cap is $4.79M.
When is Biotron Limited’s upcoming earnings report date?
Biotron Limited’s upcoming earnings report date is Mar 04, 2026 which is in 74 days.
How were Biotron Limited’s earnings last quarter?
Biotron Limited released its earnings results on Aug 27, 2025. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
Is Biotron Limited overvalued?
According to Wall Street analysts Biotron Limited’s price is currently Overvalued.
Does Biotron Limited pay dividends?
Biotron Limited does not currently pay dividends.
What is Biotron Limited’s EPS estimate?
Biotron Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotron Limited have?
Biotron Limited has 2,409,199,200 shares outstanding.
What happened to Biotron Limited’s price movement after its last earnings report?
Biotron Limited reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biotron Limited?
Currently, no hedge funds are holding shares in BITRF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Biotron Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BITRF Sentiment 70%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-184.73%
Trailing 12-Months
Asset Growth
94.95%
Trailing 12-Months
Company Description
Biotron Limited
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Technical Analysis
Vectus Biosystems Limited
―
Regeneus Ltd.
―
AdAlta Ltd.
―
Bio-Gene Technology Ltd.
―
Hexima Ltd
―
Ownership Overview
Options Prices
Currently, No data available
---